Clinical Trial Update: Effect of Methamphetamine on Residual Latent HIV Disease Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of methamphetamine on residual latent HIV disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Methamphetamine Dependence

Drugs mentioned

• Methamphetamine (methamphetamine)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV-1-infection, Methamphetamine-dependence | Phase 4 | Status: COMPLETED | Results posted: 2025-04-08